Abstract
Tumor cells show widespread genetic alterations that change the expression of genes driving tumor progression, including genes that maintain genomic integrity. In recent years, it has become clear that tumors frequently reactivate genes whose expression is typically restricted to germ cells. As germ cells have specialized pathways to facilitate the exchange of genetic information between homologous chromosomes, their aberrant regulation influences how cancer cells repair DNA double strand breaks (DSB). This drives genomic instability and affects the response of tumor cells to anticancer therapies. Since meiotic genes are usually transcriptionally repressed in somatic cells of healthy tissues, targeting aberrantly expressed meiotic genes may provide a unique opportunity to specifically kill cancer cells whilst sparing the non-transformed somatic cells. In this review, we highlight meiotic genes that have been reported to affect DSB repair in cancers derived from somatic cells. A better understanding of their mechanistic role in the context of homology-directed DNA repair in somatic cancers may provide useful insights to find novel vulnerabilities that can be targeted.
Highlights
In the 19th century, the hypothesis was put forward that cancers arise from embryonic remnants that remain in adult organs (Durante, 1874; Cohnheim, 1875)
It emerges that the ectopic activation of meiotic genes is detected in a wide variety of cancers, where it drives genomic instability and cancer progression
Most of the meiotic genes that are aberrantly expressed in cancer cells have a direct or indirect effect on pathways that are responsible for the repair of the double-strand break (DSB) induced by anticancer therapies
Summary
In the 19th century, the hypothesis was put forward that cancers arise from embryonic remnants that remain in adult organs (Durante, 1874; Cohnheim, 1875). It emerges that the ectopic activation of meiotic genes is detected in a wide variety of cancers, where it drives genomic instability and cancer progression.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.